Synergy CHC Corp. Number of Reportable Segments
Synergy CHC Corp. (SNYR) reported Number of Reportable Segments of 1 Segment for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-05-14
- Synergy CHC Corp. number of reportable segments for the quarter ending 2026-03-31 was 1.00 Segment.
- Synergy CHC Corp. number of reportable segments for fiscal 2025 was 1.00 Segment.
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|
| 2026-03-31 | 1.00 Segment 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | 1.00 Segment 10-K · filed 2026-04-01 | ||
| 2025-09-30 | 1.00 Segment 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |